{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T20:03:59Z","timestamp":1764187439883,"version":"3.46.0"},"reference-count":93,"publisher":"Georg Thieme Verlag KG","issue":"01","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z Gastroenterol"],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Liver transplantation (LT) has emerged as a standard of care for patients with end-stage liver disease, providing a life-saving intervention for patients with severely compromised liver function in both the acute and chronic setting. While LT has also become a routine procedure for early-stage hepatocellular carcinoma (HCC), offering a potential cure by treating both the tumor and the underlying liver disease, its relevance in the context of other malignancies such as cholangiocellular carcinoma (CCA), combined hepatocellular-cholangiocarcinoma (cHCC-CCA) or liver metastases is still the subject of intense debate and no definite recommendations have yet been established. This review summarizes the current therapeutic standards in the context of LT for gastrointestinal malignancies and provides a reflection and outlook on current scientific and clinical developments.<\/jats:p>","DOI":"10.1055\/a-2226-0123","type":"journal-article","created":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T20:12:15Z","timestamp":1704831135000},"page":"62-72","source":"Crossref","is-referenced-by-count":0,"title":["Liver transplantation meets gastrointestinal cancer"],"prefix":"10.1055","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2799-2287","authenticated-orcid":false,"given":"Sven H.","family":"Loosen","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology and Infectious Diseases, Medical Faculty and University Hospital D\u00fcsseldorf, Heinrich Heine University D\u00fcsseldorf, D\u00fcsseldorf, Germany"},{"name":"Center for Integrated Oncology Aachen Bonn Cologne D\u00fcsseldorf (CIO ABCD), D\u00fcsseldorf, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Leyh","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology and Infectious Diseases, Medical Faculty and University Hospital D\u00fcsseldorf, Heinrich Heine University D\u00fcsseldorf, D\u00fcsseldorf, Germany"},{"name":"Center for Integrated Oncology Aachen Bonn Cologne D\u00fcsseldorf (CIO ABCD), D\u00fcsseldorf, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulf Peter","family":"Neumann","sequence":"additional","affiliation":[{"name":"Department of General, Visceral and Transplantation Surgery, University Hospital RWTH Aachen, Aachen, Germany"},{"name":"Department of Surgery and Transplantation, University Hospital Essen, Essen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Bock","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology and Infectious Diseases, Medical Faculty and University Hospital D\u00fcsseldorf, Heinrich Heine University D\u00fcsseldorf, D\u00fcsseldorf, Germany"},{"name":"Center for Integrated Oncology Aachen Bonn Cologne D\u00fcsseldorf (CIO ABCD), D\u00fcsseldorf, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Weigel","sequence":"additional","affiliation":[{"name":"Center for Integrated Oncology Aachen Bonn Cologne D\u00fcsseldorf (CIO ABCD), D\u00fcsseldorf, Germany"},{"name":"Department of Gastroenterology, Hepatology and Infectious Diseases, Medical Faculty and University Hospital D\u00fcsseldorf, Heinrich Heine University D\u00fcsseldorf, D\u00fcsseldorf, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6288-8821","authenticated-orcid":false,"given":"Tom","family":"Luedde","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology and Infectious Diseases, Medical Faculty and University Hospital D\u00fcsseldorf, Heinrich Heine University D\u00fcsseldorf, D\u00fcsseldorf, Germany"},{"name":"Center for Integrated Oncology Aachen Bonn Cologne D\u00fcsseldorf (CIO ABCD), D\u00fcsseldorf, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Roderburg","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology and Infectious Diseases, Medical Faculty and University Hospital D\u00fcsseldorf, Heinrich Heine University D\u00fcsseldorf, D\u00fcsseldorf, Germany"},{"name":"Center for Integrated Oncology Aachen Bonn Cologne D\u00fcsseldorf (CIO ABCD), D\u00fcsseldorf, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2024,1,9]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/ajt.16494","article-title":"OPTN\/SRTR 2019 Annual Data Report: Liver","volume":"21","author":"AJ Kwong","year":"2021","journal-title":"Am J Transplant"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/liv.13651","article-title":"How to improve long-term outcome after liver transplantation?","volume":"38","author":"F Durand","year":"2018","journal-title":"Liver Int"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1111\/tri.13358","article-title":"2018 Annual Report of the European Liver Transplant Registry (ELTR) \u2013 50-year evolution of liver transplantation","volume":"31","author":"R Adam","year":"2018","journal-title":"Transpl Int"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"623","DOI":"10.5306\/wjco.v12.i8.623","article-title":"Liver transplantation in malignant disease","volume":"12","author":"SA Lang","year":"2021","journal-title":"WJCO"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3238\/arztebl.m2021.0210","article-title":"Hospital Mortality and Current Trends in Liver Transplantation in Germany\u2014a Systematic Analysis of Standardized Hospital Discharge Data, 2008\u20132017","volume":"118","author":"SH Loosen","year":"2021","journal-title":"Dtsch Arztebl Int"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.surg.2018.10.024","article-title":"What is transplant oncology?","volume":"165","author":"T Hibi","year":"2019","journal-title":"Surgery"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: trends, risk, prevention and management","volume":"16","author":"JD Yang","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00423-020-02052-1","article-title":"Prognostic evaluation of HCC patients undergoing surgical resection: an analysis of 8 different staging systems","volume":"406","author":"J Bednarsch","year":"2021","journal-title":"Langenbecks Arch Surg"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1002\/lt.24758","article-title":"Liver transplantation versus liver resection for hepatocellular carcinoma in intention to treat: An attempt to perform an ideal meta-analysis","volume":"23","author":"B Menahem","year":"2017","journal-title":"Liver Transpl"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"3096","DOI":"10.1245\/s10434-014-3808-1","article-title":"Is resection or transplantation the ideal treatment in patients with hepatocellular carcinoma in cirrhosis if both are possible? A systematic review and metaanalysis","volume":"21","author":"A Proneth","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis","volume":"334","author":"V Mazzaferro","year":"1996","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.21037\/tgh.2020.01.06","article-title":"Comparison between Milan and UCSF criteria for liver transplantation in patients with hepatocellular carcinoma: a systematic review and meta-analysis","volume":"6","author":"JH Bento de Sousa","year":"2021","journal-title":"Transl Gastroenterol Hepatol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S1470-2045(08)70284-5","article-title":"Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis","volume":"10","author":"V Mazzaferro","year":"2009","journal-title":"Lancet Oncol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1053\/jhep.2001.24563","article-title":"Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival","volume":"33","author":"FY Yao","year":"2001","journal-title":"Hepatology"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1002\/lt.23904","article-title":"Alpha-fetoprotein level > 1000 ng\/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria","volume":"20","author":"B Hameed","year":"2014","journal-title":"Liver Transpl"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/tri.13391","article-title":"Expanded living-donor liver transplantation criteria for patients with hepatocellular carcinoma based on the Japanese nationwide survey: the 5\u20135-500 rule \u2013 a retrospective study","volume":"32","author":"T Shimamura","year":"2019","journal-title":"Transpl Int"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1053\/j.gastro.2017.09.025","article-title":"Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma","volume":"154","author":"V Mazzaferro","year":"2018","journal-title":"Gastroenterology"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.jhep.2020.03.018","article-title":"Including mRECIST in the Metroticket 2.0 criteria improves prediction of hepatocellular carcinoma-related death after liver transplant","volume":"73","author":"A Cucchetti","year":"2020","journal-title":"J Hepatol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1002\/hep.30838","article-title":"Charting the Path Forward for Risk Prediction in Liver Transplant for Hepatocellular Carcinoma: International Validation of HALTHCC Among 4,089 Patients","volume":"71","author":"DJ Firl","year":"2020","journal-title":"Hepatology"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/S2468-1253(17)30106-1","article-title":"Development and validation of the HALT-HCC score to predict mortality in liver transplant recipients with hepatocellular carcinoma: a retrospective cohort analysis","volume":"2","author":"K Sasaki","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1016\/j.jhep.2020.12.021","article-title":"Predicting survival after liver transplantation in patients with hepatocellular carcinoma using the LiTES-HCC score","volume":"74","author":"D Goldberg","year":"2021","journal-title":"J Hepatol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"220","DOI":"10.14218\/JCTH.2020.00037","article-title":"Hepatocellular Carcinoma: Downstaging to Liver Transplantation as Curative Therapy","volume":"9","author":"L Frankul","year":"2021","journal-title":"J Clin Transl Hepatol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/hep.29086","article-title":"AASLD guidelines for the treatment of hepatocellular carcinoma","volume":"67","author":"JK Heimbach","year":"2018","journal-title":"Hepatology"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/hep.29485","article-title":"Therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta-analysis","volume":"67","author":"L Kulik","year":"2018","journal-title":"Hepatology"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1097\/TP.0000000000001571","article-title":"The International Liver Transplantation Society Living Donor Liver Transplant Recipient Guideline","volume":"101","author":"CM Miller","year":"2017","journal-title":"Transplantation"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis","volume":"334","author":"V Mazzaferro","year":"1996","journal-title":"N Engl J Med"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1159\/000106910","article-title":"Living donor liver transplantation for hepatocellular carcinoma: Tokyo University series","volume":"25","author":"Y Sugawara","year":"2007","journal-title":"Dig Dis"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/lt.21368","article-title":"Liver transplantation in patients with hepatocellular carcinoma across Milan criteria","volume":"14","author":"JI Herrero","year":"2008","journal-title":"Liver Transpl"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1002\/lt.21576","article-title":"Expanded criteria for liver transplantation in patients with cirrhosis and hepatocellular carcinoma","volume":"14","author":"M Silva","year":"2008","journal-title":"Liver Transpl"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/hep.27787","article-title":"Total tumor volume and alpha-fetoprotein for selection of transplant candidates with hepatocellular carcinoma: A prospective validation","volume":"62","author":"C Toso","year":"2015","journal-title":"Hepatology"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.surg.2013.04.056","article-title":"Usefulness of the Kyoto criteria as expanded selection criteria for liver transplantation for hepatocellular carcinoma","volume":"154","author":"T Kaido","year":"2013","journal-title":"Surgery"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"E491","DOI":"10.1111\/j.1399-0012.2011.01463.x","article-title":"Comparative evaluation of expanded criteria for patients with hepatocellular carcinoma beyond the Milan criteria undergoing living-related donor liver transplantation","volume":"25","author":"K Shirabe","year":"2011","journal-title":"Clin Transplant"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1002\/lt.24169","article-title":"Downstaging hepatocellular carcinoma: A systematic review and pooled analysis","volume":"21","author":"ND Parikh","year":"2015","journal-title":"Liver Transpl"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1002\/hep.27752","article-title":"Downstaging of hepatocellular cancer before liver transplant: long-term outcome compared to tumors within Milan criteria","volume":"61","author":"FY Yao","year":"2015","journal-title":"Hepatology"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/S1470-2045(20)30224-2","article-title":"Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b\/3 trial","volume":"21","author":"V Mazzaferro","year":"2020","journal-title":"Lancet Oncol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.1038\/s41467-020-17670-y","article-title":"A decade of immune-checkpoint inhibitors in cancer therapy","volume":"11","author":"C Robert","year":"2020","journal-title":"Nat Commun"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"5863","DOI":"10.3390\/curroncol30060439","article-title":"Current Landscape of Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma","volume":"30","author":"SM Ruff","year":"2023","journal-title":"Curr Oncol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"ix186","DOI":"10.1093\/annonc\/mdz446.002","article-title":"IMbrave150: Efficacy and safety results from a ph III study evaluating atezolizumab (atezo) + bevacizumab (bev) vs sorafenib (Sor) as first treatment (tx) for patients (pts) with unresectable hepatocellular carcinoma (HCC)","volume":"30","author":"A-L Cheng","year":"2019","journal-title":"Annals of Oncology"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2100070","article-title":"Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma","volume":"1","author":"GK Abou-Alfa","year":"2022","journal-title":"NEJM Evidence"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/hep.31697","article-title":"Perspectives on the Neoadjuvant Use of Immunotherapy in Hepatocellular Carcinoma","volume":"74","author":"DJ Pinato","year":"2021","journal-title":"Hepatology"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1111\/ajt.15617","article-title":"Fatal hepatic necrosis after nivolumab as a bridge to liver transplant for HCC: Are checkpoint inhibitors safe for the pretransplant patient?","volume":"20","author":"MF Nordness","year":"2020","journal-title":"Am J Transplant"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"101386","DOI":"10.1016\/j.trim.2021.101386","article-title":"Pretransplant use of toripalimab for hepatocellular carcinoma resulting in fatal acute hepatic necrosis in the immediate postoperative period","volume":"66","author":"G-H Chen","year":"2021","journal-title":"Transpl Immunol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1111\/apt.15253","article-title":"Systematic review with meta-analysis: sirolimus- or everolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma","volume":"49","author":"SE Grigg","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.jhep.2013.07.012","article-title":"Reduced exposure to calcineurin inhibitors early after liver transplantation prevents recurrence of hepatocellular carcinoma","volume":"59","author":"M Rodr\u00edguez-Per\u00e1lvarez","year":"2013","journal-title":"J Hepatol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/TP.0000000000000965","article-title":"Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial","volume":"100","author":"EK Geissler","year":"2016","journal-title":"Transplantation"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1097\/SLA.0000000000004280","article-title":"mTOR Inhibition Is Most Beneficial After Liver Transplantation for Hepatocellular Carcinoma in Patients With Active Tumors","volume":"272","author":"AA Schnitzbauer","year":"2020","journal-title":"Ann Surg"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.transproceed.2020.09.021","article-title":"Long-Term Outcomes of Everolimus Therapy in De Novo Liver Transplantation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"53","author":"KI Bzeizi","year":"2021","journal-title":"Transplant Proc"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.jhep.2019.11.020","article-title":"Liver resection and transplantation for intrahepatic cholangiocarcinoma","volume":"72","author":"V Mazzaferro","year":"2020","journal-title":"J Hepatol"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s11605-007-0335-4","article-title":"Outcomes analysis for 280 patients with cholangiocarcinoma treated with liver transplantation over an 18-year period","volume":"12","author":"NS Becker","year":"2008","journal-title":"J Gastrointest Surg"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/s0002-9610(05)80696-8","article-title":"Is liver transplantation indicated for cholangiocarcinoma?","volume":"166","author":"RM Goldstein","year":"1993","journal-title":"Am J Surg"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1002\/hep.28744","article-title":"Liver transplantation for \u201every early\u201c intrahepatic cholangiocarcinoma: International retrospective study supporting a prospective assessment","volume":"64","author":"G Sapisochin","year":"2016","journal-title":"Hepatology"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1097\/SLA.0000000000000494","article-title":"Intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma in patients undergoing liver transplantation: a Spanish matched cohort multicenter study","volume":"259","author":"G Sapisochin","year":"2014","journal-title":"Ann Surg"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.hpb.2015.10.001","article-title":"Long-term outcome of patients undergoing liver transplantation for mixed hepatocellular carcinoma and cholangiocarcinoma: an analysis of the UNOS database","volume":"18","author":"V Vilchez","year":"2016","journal-title":"HPB (Oxford)"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/TP.0000000000000286","article-title":"Tumors with intrahepatic bile duct differentiation in cirrhosis: implications on outcomes after liver transplantation","volume":"99","author":"ME Facciuto","year":"2015","journal-title":"Transplantation"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S2468-1253(18)30045-1","article-title":"Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-series","volume":"3","author":"KE Lunsford","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1111\/ajt.16906","article-title":"Survival following liver transplantation for locally advanced, unresectable intrahepatic cholangiocarcinoma","volume":"22","author":"RR McMillan","year":"2022","journal-title":"Am J Transplant"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1097\/00007890-200004270-00019","article-title":"Liver transplantation for cholangiocarcinoma: results in 207 patients","volume":"69","author":"CG Meyer","year":"2000","journal-title":"Transplantation"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1053\/jlts.2001.29419","article-title":"Liver transplantation for cholangiocellular carcinoma: analysis of a single-center experience and review of the literature","volume":"7","author":"M Shimoda","year":"2001","journal-title":"Liver Transpl"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1097\/01.sla.0000108702.45715.81","article-title":"Spanish experience in liver transplantation for hilar and peripheral cholangiocarcinoma","volume":"239","author":"R Robles","year":"2004","journal-title":"Ann Surg"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.jhep.2004.01.002","article-title":"Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy","volume":"40","author":"B Brandsaeter","year":"2004","journal-title":"J Hepatol"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1007\/s11605-020-04721-4","article-title":"Liver Transplantation for Peri-hilar Cholangiocarcinoma","volume":"24","author":"EK Tan","year":"2020","journal-title":"J Gastrointest Surg"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/j.1432-2277.2010.01108.x","article-title":"Liver transplantation for cholangiocarcinoma","volume":"23","author":"CB Rosen","year":"2010","journal-title":"Transpl Int"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1097\/SLA.0000000000005641","article-title":"Liver Transplantation as a New Standard of Care in Patients With Perihilar Cholangiocarcinoma? Results From an International Benchmark Study","volume":"276","author":"E Breuer","year":"2022","journal-title":"Ann Surg"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1097\/SLA.0000000000003801","article-title":"Meta-analysis and Meta-regression of Survival After Liver Transplantation for Unresectable Perihilar Cholangiocarcinoma","volume":"273","author":"WA Cambridge","year":"2021","journal-title":"Ann Surg"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1097\/SLA.0000000000002574","article-title":"Transplantation Versus Resection for Hilar Cholangiocarcinoma: An Argument for Shifting Treatment Paradigms for Resectable Disease","volume":"267","author":"CG Ethun","year":"2018","journal-title":"Ann Surg"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1097\/SLA.0000000000002716","article-title":"Transplantation Versus Resection for Hilar Cholangiocarcinoma: An Argument for Shifting Paradigms for Resectable Disease in Annals of Surgery 2018","volume":"267","author":"CB Rosen","year":"2018","journal-title":"Ann Surg"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2147\/JHC.S159805","article-title":"Combined hepatocellular cholangiocarcinoma (cHCC-CC): an update of genetics, molecular biology, and therapeutic interventions","volume":"6","author":"C Stavraka","year":"2019","journal-title":"J Hepatocell Carcinoma"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1002\/lt.23897","article-title":"Combined hepatocellular-cholangiocarcinoma: a population-level analysis of an uncommon primary liver tumor","volume":"20","author":"M Garancini","year":"2014","journal-title":"Liver Transpl"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1002\/jso.23289","article-title":"Transplantation versus resection for patients with combined hepatocellular carcinoma-cholangiocarcinoma","volume":"107","author":"RT Groeschl","year":"2013","journal-title":"J Surg Oncol"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1016\/j.transproceed.2013.08.056","article-title":"Long-term outcome of liver transplantation for combined hepatocellular carcinoma and cholangiocarcinoma","volume":"45","author":"Y-H Park","year":"2013","journal-title":"Transplant Proc"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1097\/TP.0000000000003212","article-title":"Liver Transplantation for Cholangiocarcinoma and Mixed Hepatocellular Cholangiocarcinoma: Working Group Report From the ILTS Transplant Oncology Consensus Conference","volume":"104","author":"G Sapisochin","year":"2020","journal-title":"Transplantation"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1002\/lt.24711","article-title":"Longterm prognosis of combined hepatocellular carcinoma-cholangiocarcinoma following liver transplantation and resection","volume":"23","author":"D-H Jung","year":"2017","journal-title":"Liver Transpl"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.hbpd.2018.10.001","article-title":"Long-term outcomes of combined hepatocellular-cholangiocarcinoma after hepatectomy or liver transplantation: A systematic review and meta-analysis","volume":"18","author":"D-B Li","year":"2019","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.jamcollsurg.2020.11.017","article-title":"Multi-Center Analysis of Liver Transplantation for Combined Hepatocellular Carcinoma-Cholangiocarcinoma Liver Tumors","volume":"232","author":"LA Dageforde","year":"2021","journal-title":"J Am Coll Surg"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ijscr.2020.07.069","article-title":"Living donor liver transplantation for combined hepatocellular-cholangiocarcinoma: A case series of four patients","volume":"74","author":"T Ito","year":"2020","journal-title":"Int J Surg Case Rep"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"100745","DOI":"10.1016\/j.jhepr.2023.100745","article-title":"An international multicentre evaluation of treatment strategies for combined hepatocellular-cholangiocarcinoma\u2730","volume":"5","author":"MPAW Claasen","year":"2023","journal-title":"JHEP Rep"},{"key":"ref77","first-page":"1567","article-title":"Is orthotopic liver transplantation a feasible treatment for secondary cancer of the liver?","volume":"23","author":"F M\u00fchlbacher","year":"1991","journal-title":"Transplant Proc"},{"key":"ref78","first-page":"726","article-title":"Hepatic transplantation for primary and metastatic cancers of the liver","volume":"110","author":"I Penn","year":"1991","journal-title":"Surgery"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1634\/theoncologist.2-3-164","article-title":"Indications and Role of Liver Transplantation for Malignant Tumors","volume":"2","author":"R Pichlmayr","year":"1997","journal-title":"Oncologist"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1016\/S1470-2045(13)70362-0","article-title":"Recommendations for management of patients with neuroendocrine liver metastases","volume":"15","author":"A Frilling","year":"2014","journal-title":"Lancet Oncol"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.surg.2017.05.006","article-title":"Liver transplantation in patients with liver metastases from neuroendocrine tumors: A systematic review","volume":"162","author":"D Moris","year":"2017","journal-title":"Surgery"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1097\/SLA.0b013e31828ee17c","article-title":"Liver transplantation for neuroendocrine tumors in Europe-results and trends in patient selection: a 213-case European liver transplant registry study","volume":"257","author":"YP Le Treut","year":"2013","journal-title":"Ann Surg"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.jhep.2007.07.004","article-title":"Neuroendocrine tumors metastatic to the liver: how to select patients for liver transplantation?","volume":"47","author":"V Mazzaferro","year":"2007","journal-title":"J Hepatol"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1111\/ajt.13831","article-title":"The Long-Term Benefit of Liver Transplantation for Hepatic Metastases From Neuroendocrine Tumors","volume":"16","author":"V Mazzaferro","year":"2016","journal-title":"Am J Transplant"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"601","DOI":"10.21037\/jgo.2019.11.03","article-title":"Liver transplantation in the treatment of unresectable hepatic metastasis from neuroendocrine tumors","volume":"11","author":"J Kim","year":"2020","journal-title":"J Gastrointest Oncol"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1097\/SLA.0b013e3182823957","article-title":"Liver transplantation for nonresectable liver metastases from colorectal cancer","volume":"257","author":"M Hagness","year":"2013","journal-title":"Ann Surg"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1097\/SLA.0000000000003404","article-title":"Survival Following Liver Transplantation for Patients With Nonresectable Liver-only Colorectal Metastases","volume":"271","author":"S Dueland","year":"2020","journal-title":"Annals of Surgery"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"100570","DOI":"10.1016\/j.trre.2020.100570","article-title":"The role of liver transplantation for colorectal liver metastases: A systematic review and pooled analysis","volume":"34","author":"D Giannis","year":"2020","journal-title":"Transplant Rev (Orlando)"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1097\/TP.0000000000003118","article-title":"Liver Transplantation for Colorectal and Neuroendocrine Liver Metastases and Hepatoblastoma. Working Group Report From the ILTS Transplant Oncology Consensus Conference","volume":"104","author":"T Hibi","year":"2020","journal-title":"Transplantation"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1378\/chest.11-0039","article-title":"Clinical patterns and outcome in epithelioid hemangioendothelioma with or without pulmonary involvement: insights from an internet registry in the study of a rare cancer","volume":"140","author":"K Lau","year":"2011","journal-title":"Chest"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1097\/SLA.0b013e31815c2a70","article-title":"The place of liver transplantation in the treatment of hepatic epitheloid hemangioendothelioma: report of the European liver transplant registry","volume":"246","author":"JP Lerut","year":"2007","journal-title":"Ann Surg"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1097\/TP.0000000000001603","article-title":"Hepatic Epithelioid Hemangioendothelioma and Adult Liver Transplantation: Proposal for a Prognostic Score Based on the Analysis of the ELTR-ELITA Registry","volume":"101","author":"Q Lai","year":"2017","journal-title":"Transplantation"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1002\/cncr.22225","article-title":"Primary malignant hepatic epithelioid hemangioendothelioma: a comprehensive review of the literature with emphasis on the surgical therapy","volume":"107","author":"A Mehrabi","year":"2006","journal-title":"Cancer"}],"container-title":["Zeitschrift f\u00fcr Gastroenterologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2226-0123.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T20:02:21Z","timestamp":1764187341000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2226-0123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":93,"journal-issue":{"issue":"01","published-online":{"date-parts":[[2024,1,9]]},"published-print":{"date-parts":[[2024,1]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2226-0123","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0044-2771","1439-7803"],"issn-type":[{"type":"print","value":"0044-2771"},{"type":"electronic","value":"1439-7803"}],"subject":[],"published":{"date-parts":[[2024,1]]}}}